Skip to main content
TipRanks
Go Ultimate75% OFF

HLB Life Science Co.,Ltd. (067630) Stock Price & Analysis

067630 Stock Chart & Stats

â‚©2,350.00â‚©5.00(0.21%)
At close: 3:30 PM GMT+9
â‚©3Kâ‚©4KAug 24Sep 7Sep 21Oct 6Oct 19Nov 2Nov 16
Day’s Range
KRW 2,290.00 - KRW 2,365.00
52-Week Range
KRW 1,608.00 - KRW 5,330.00
Previous Close
KRW 2,345.00
Volume
N/A
Average Volume (3M)
328.19K
Market Cap
KRW 286.34B
Enterprise Value
KRW 547.93B
Total Cash (Recent Filing)
KRW 13.88B
Total Debt (Recent Filing)
KRW 160.36B
Price to Earnings (P/E)
―
Beta
0.52
Next Earnings
Mar 25, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Equity Base

A meaningful equity base provides some financial resilience and gives the company a larger capital cushion against operating losses. Although that cushion is being pressured, it may still support ongoing R&D and commercialization efforts while management works to restore profitability.

Prior Earnings Recovery

The 2024 profit and modest revenue growth demonstrate that the business has at least temporarily achieved improved operating outcomes. While the recovery was not sustained in 2025, this history indicates potential earnings sensitivity to successful products, cost control, or commercialization progress.

Non-Cash Loss Component

Free cash flow being less negative than net income in some periods suggests that reported losses are not entirely matched by immediate cash outflows. This does not remove the funding challenge, but it may reduce the pace at which accounting losses consume available resources.

Bears Say

Revenue And Profit Volatility

Sharp revenue contraction and the reversal from profit to a very large loss indicate that the current business model lacks stable earnings power. Persistently inconsistent margins, including negative gross margins in most years, could limit reinvestment and make future performance highly dependent on successful recovery.

Persistent Cash Burn

Sustained negative operating and free cash flow means the company is not currently self-financing its activities. Continued cash burn increases reliance on financing or existing balance-sheet resources, potentially limiting the funds available for drug development, commercialization, and other strategic priorities.

Worsening Leverage

Higher debt relative to equity reduces financial flexibility while the company is already generating losses and negative cash flow. The simultaneous decline in equity and sharply negative 2025 return on equity suggests that the capital base is under pressure and may provide diminishing protection over time.

067630 FAQ

What was HLB Life Science Co.,Ltd.’s price range in the past 12 months?
HLB Life Science Co.,Ltd. lowest stock price was â‚©1608.00 and its highest was â‚©5330.00 in the past 12 months.
What is HLB Life Science Co.,Ltd.’s market cap?
HLB Life Science Co.,Ltd.’s market cap is ₩286.34B.
When is HLB Life Science Co.,Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were HLB Life Science Co.,Ltd.’s earnings last quarter?
HLB Life Science Co.,Ltd. released its earnings results on Aug 07, 2026. The company reported -â‚©71.389 earnings per share for the quarter.
Is HLB Life Science Co.,Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does HLB Life Science Co.,Ltd. pay dividends?
HLB Life Science Co.,Ltd. does not currently pay dividends.
What is HLB Life Science Co.,Ltd.’s EPS estimate?
HLB Life Science Co.,Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HLB Life Science Co.,Ltd. have?
HLB Life Science Co.,Ltd. has 121,917,060 shares outstanding.
What happened to HLB Life Science Co.,Ltd.’s price movement after its last earnings report?
HLB Life Science Co.,Ltd. reported an EPS of -â‚©71.389 in its last earnings report. Following the earnings report the stock price went down -1.566%.
Which hedge fund is a major shareholder of HLB Life Science Co.,Ltd.?
Currently, no hedge funds are holding shares in KR:067630
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology